Showing results (1201-1210 of 1,344) with videos related to

Sort By:
Pageof 135
The Pharmacogenomics Journal|December 9, 2015
A systematic review and meta-analysis of the impact of WT1 polymorphism rs16754 in the effectiveness of standard chemotherapy in patients with acute myeloid leukemiaJ E Megías-Vericat, M J Herrero, L Rojas, et al.
The Pharmacogenomics Journal|November 22, 2017
The PNPLA3 I148M variant is associated with transaminase elevations in type 2 diabetes patients treated with basal insulin peglisproS Pillai, S Duvvuru, P Bhatnagar, et al.
The Pharmacogenomics Journal|December 6, 2017
Gene expression and linkage analysis implicate CBLB as a mediator of rituximab resistanceJ Jack, G W Small, C C Brown, et al.
The Pharmacogenomics Journal|July 6, 2016
Effect of ABCB1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotypeT Vanhove, P Annaert, D Lambrechts, et al.
The Pharmacogenomics Journal|March 10, 2018
Evaluation of a clinical pharmacogenetics model to predict methotrexate response in patients with rheumatoid arthritisRosario López-Rodríguez, Aida Ferreiro-Iglesias, Aurea Lima, et al.
The Pharmacogenomics Journal|January 7, 2018
Astrocyte-specific transcriptome responses to chronic ethanol consumptionEmma K Erickson, Sean P Farris, Yuri A Blednov, et al.
The Pharmacogenomics Journal|January 5, 2018
Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin CohortPayman Shahabi, Félix Lamothe, Stéphanie Dumas, et al.
The Pharmacogenomics Journal|January 17, 2019
An economic model of the cost-utility of pre-emptive genetic testing to support pharmacotherapy in patients with major depression in primary careReinier L Sluiter, Joost G E Janzing, Gert Jan van der Wilt, et al.
The Pharmacogenomics Journal|January 18, 2019
Prognostic role of genetic polymorphisms of the interleukin-6 signaling pathway in patients with severe heart failurePeter R Hansen, Karl Emil Nelveg-Kristensen, Henrik B Rasmussen, et al.
The Pharmacogenomics Journal|August 9, 2007
The mitochondrial pharmacogenomics of haplogroup T: MTND2*LHON4917G and antiretroviral therapy-associated peripheral neuropathyJ A Canter, D W Haas, A R Kallianpur, et al.
Pageof 135